Medexus Pharmaceuticals Ratios and Metrics

Market cap in millions CAD. Fiscal year is April - March.

Millions CAD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 1, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	127	78	39	32	63	151
Market Cap Growth	65.19%	98.25%	21.95%	-48.46%	-58.62%	335.06%
Enterprise Value	141	123	98	109	118	204
Last Close Price	3.96	2.42	1.61	1.60	3.14	7.90
PE Ratio	-	24.17	-	19.55	-	-
PS Ratio	0.93	0.50	0.26	0.22	0.65	1.51
PB Ratio	1.77	1.04	0.96	1.06	2.82	6.68
P/FCF Ratio	5.39	2.28	1.56	-	-	24.45
P/OCF Ratio	5.33	2.26	1.55	-	-	23.88
EV/Sales Ratio	1.03	0.79	0.64	0.74	1.23	2.04
EV/EBITDA Ratio	7.56	4.53	3.91	5.59	-	25.52
EV/EBIT Ratio	26.46	7.20	5.64	9.46	-	221.81
EV/FCF Ratio	6.00	3.60	3.86	-	-	32.94
Debt / Equity Ratio	0.49	0.71	1.65	3.12	3.08	2.49
Debt / EBITDA Ratio	1.86	1.95	2.68	4.81	-	6.69
Debt / FCF Ratio	1.48	1.56	2.67	-	-	9.12
Net Debt / Equity Ratio	0.20	0.25	1.47	2.54	2.52	1.45
Net Debt / EBITDA Ratio	0.77	0.70	2.42	3.97	-6.94	4.12
Net Debt / FCF Ratio	0.61	0.55	2.39	-37.88	-35.12	5.32
Asset Turnover	0.66	0.66	0.71	0.72	0.53	0.59
Inventory Turnover	1.12	1.17	1.61	1.92	1.83	2.24
Quick Ratio	0.43	0.38	0.44	0.43	0.51	0.94
Current Ratio	1.12	0.83	1.10	0.87	1.02	1.47
Return on Equity (ROE)	-0.64%	5.45%	-0.81%	6.07%	-16.08%	-133.66%
Return on Assets (ROA)	1.62%	4.55%	5.04%	3.53%	-5.38%	0.34%
Return on Invested Capital (ROIC)	6.14%	16.99%	-33.43%	11.95%	-23.17%	1.43%
Return on Capital Employed (ROCE)	4.20%	16.00%	14.30%	10.90%	-13.60%	0.70%
Earnings Yield	-0.29%	4.14%	-0.74%	5.12%	-5.74%	-23.48%
FCF Yield	18.55%	43.91%	64.18%	-6.31%	-2.54%	4.09%
Buyback Yield / Dilution	-28.99%	-18.76%	-8.76%	-3.36%	-30.65%	-5.83%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.